The effect of the irreversible μ-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNA
- 12 December 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 287 (2) , 135-143
- https://doi.org/10.1016/0014-2999(95)00488-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The Effect of Intrinsic Efficacy on Opioid ToleranceAnesthesiology, 1995
- CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexoneBrain Research Bulletin, 1995
- Ethanol and naloxone differentially upregulate delta opioid receptor gene expression in neuroblastoma hybrid (NG108-15) cellsMolecular Brain Research, 1994
- Strain differences in the analgesic potency of morphine and in mu opioid receptor mRNA levels in adult male miceRegulatory Peptides, 1994
- Mu opioid receptor mRNA levels following chronic naltrexone administrationRegulatory Peptides, 1994
- Quantitation of NMDA receptor (NMDAR1) mRNA levels in the adult and developing rat CNSMolecular Brain Research, 1993
- Effect of adrenal and sex hormones on opioid analgesia and opioid receptor regulationPharmacology Biochemistry and Behavior, 1992
- Effects of intracerebroventricular β-funaltrexamine on μ and δ opioid receptors in the rat: dichotomy between binding and antinociceptionEuropean Journal of Pharmacology, 1991
- Effects of stress and β-funal trexamine pretreatment on morphine analgesia and opioid binding in ratsLife Sciences, 1987
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976